← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2004Last known activity
Dec 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06274879CollaboratorPhase 2Dec 1, 2024
- NCT04997317CollaboratorEarly Phase 1Apr 21, 2021
- NCT00744640CollaboratorPhase 1/Phase 2Oct 1, 2005
- NCT00107081CollaboratorPhase 3Jan 1, 2004
Details
- Last known activity
- Dec 1, 2024